Lactiga accepted to the Princeton Growth Accelerator Lactiga joins the Princeton Growth Accelerator which provides networking, physical space, mentoring, etc. Expanding our footprint into the New Jersey biotechnology cluster is an important part of Lactiga’s...
Lactiga Announces NIH-Funded Partnership with Mount Sinai Lactiga announced today a collaboration agreement with the Icahn School of Medicine at Mount Sinai to advance preclinical research into LCTG-001 as a potential treatment for COVID-19 patients. The collaborative...
Lactiga wins the Business Innovation Award Lactiga was selected as the Winner in the Business Innovation category of the Small & Mighty Summit, a forum to showcase businesses in the Greater Toronto Region, in recognition of our efforts at novel therapeutics for...
Original Post PRINCETON, N.J.--(BUSINESS WIRE)--Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement ...
